組織黏合劑管道 - 發展階段、細分市場、地區和國家、監管途徑、主要參與者(2024 年版)
市場調查報告書
商品編碼
1590402

組織黏合劑管道 - 發展階段、細分市場、地區和國家、監管途徑、主要參與者(2024 年版)

Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: | 出版商: GlobalData | 英文 57 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

本報告提供了有關組織黏合劑管道產品的全面信息,包括處於不同開發階段的產品的比較分析以及正在進行的臨床試驗的數據。

目錄

第 1 章目錄

第 2 章簡介

第3章開發中的產品

  • 組織黏合劑 - 管道產品:依開發階段劃分
  • 組織黏合劑 - 管道產品:按細分市場
  • 組織黏合劑 - 管道產品:按地區
  • 組織黏合劑 - 管道產品:依監管途徑
  • 組織黏合劑 - 管道產品:預計核准日期
  • 組織黏合劑 - 正在進行的臨床試驗

第 4 章組織黏合劑 - 各公司正在開發的管道產品

  • 組織黏合劑公司 - 管道產品:依發展階段劃分
  • 組織黏合劑 - 管道產品:依開發階段劃分

第五章組織黏合劑企業及產品概述

  • Adhesys Medical GmbH:公司概況
    • Adhesys Medical GmbH:管道產品和正在進行的臨床試驗概述
  • Advanced Medical Solutions Group plc:公司概況
    • Advanced Medical Solutions Group plc:管道產品和正在進行的臨床試驗概述
  • Aleo BME Inc:公司概況
    • Aleo BME Inc:管道產品和正在進行的臨床試驗概述
  • Alumend LLC:公司概況
    • Alumend LLC:管道產品和正在進行的臨床試驗概述
  • Artivion Inc:公司概況
    • Artivion Inc:管道產品和正在進行的臨床試驗概述
  • BioDevek Inc:公司概況
    • BioDevek Inc:管道產品和正在進行的臨床試驗概述
  • DialyFlux LLC:公司概況
    • DialyFlux LLC:管道產品和正在進行的臨床試驗概述
  • 埃默裡大學:公司概況
    • 埃默裡大學:管道產品和正在進行的臨床試驗概述
  • Hansjorg Wyss 仿生工程研究所:公司概況
    • Hansjorg Wyss 生物啟發工程研究所:管道產品和正在進行的臨床試驗概述
  • 哈佛大學:公司概況
    • 哈佛大學:管道產品和正在進行的臨床試驗概述
  • Kollodis BioSciences Inc:公司概況
    • Kollodis BioSciences Inc:管道產品和正在進行的臨床試驗概述
  • 麻省理工學院:公司概況
    • 麻省理工學院:管道產品和正在進行的臨床試驗概述
  • Medisse BV(不活躍):公司概覽
    • Medisse BV(不活躍):管道產品和正在進行的臨床試驗概述
  • N8 Medical LLC:公司概況
    • N8 Medical LLC:管道產品和正在進行的臨床試驗概述
  • 南洋理工大學:公司概況
    • 南洋理工大學:管道產品和正在進行的臨床試驗概述
  • 西北大學:公司概況
    • 西北大學:管道產品和正在進行的臨床試驗概述
  • OptMed Inc:公司概況
    • OptMed Inc:管道產品和正在進行的臨床試驗概述
  • 普渡大學:公司概況
    • 普渡大學:管道產品和正在進行的臨床試驗概述
  • Tissium SA:公司概況
    • Tissium SA:管道產品和正在進行的臨床試驗概述
  • 戈爾韋大學:公司概況
    • 戈爾韋大學:管道產品和正在進行的臨床試驗概述
  • 堪薩斯大學:公司概況
    • 堪薩斯大學:管道產品和正在進行的臨床試驗概述

第 6 章組織黏合劑 - 最新進展

  • 2024 年 8 月 30 日:Okapi Medical 獲得 Cutiva 局部皮膚黏合劑的 510(k) 許可
  • 2024 年 7 月 29 日:Connexicon Medical 獲得 FDA 510(k) CM005 標準 (CM005) 許可
  • 2024 年 7 月 29 日:Connexicon Medical 的 CM00622 LINC 皮膚閉合系統 (CM00622 LINC) 獲得 FDA 510(k) 許可
  • 2024 年 7 月 29 日:Connexicon 獲得 FDA 510(k) CM004 Mini (CM004) 許可
  • 2024 年 3 月 22 日:Meril Endo 手術公司的 Meriglu 局部皮膚黏合劑獲得 FDA 510(K) 批准
  • 2023 年 10 月 18 日:NeoDyne 在英國開設新總部,慶祝在英國的成長與擴張

第7章附錄

Product Code: GDME1861EPD

GlobalData's Medical Devices sector report, "Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Tissue Adhesives pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. Tissue adhesives allows for proper healing of the wound under the film and protects the wound from microbial infections.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Adhesives under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Adhesives and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Adhesives under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Tissue Adhesives Overview

3 Products under Development

  • 3.1 Tissue Adhesives - Pipeline Products by Stage of Development
  • 3.2 Tissue Adhesives - Pipeline Products by Segment
  • 3.3 Tissue Adhesives - Pipeline Products by Territory
  • 3.4 Tissue Adhesives - Pipeline Products by Regulatory Path
  • 3.5 Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • 3.6 Tissue Adhesives - Ongoing Clinical Trials

4 Tissue Adhesives - Pipeline Products under Development by Companies

  • 4.1 Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • 4.2 Tissue Adhesives - Pipeline Products by Stage of Development

5 Tissue Adhesives Companies and Product Overview

  • 5.1 Adhesys Medical GmbH Company Overview
    • 5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Advanced Medical Solutions Group plc Company Overview
    • 5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Aleo BME Inc Company Overview
    • 5.3.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Alumend LLC Company Overview
    • 5.4.1 Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Artivion Inc Company Overview
    • 5.5.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 BioDevek Inc Company Overview
    • 5.6.1 BioDevek Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 DialyFlux LLC Company Overview
    • 5.7.1 DialyFlux LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Emory University Company Overview
    • 5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
    • 5.9.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Harvard University Company Overview
    • 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Kollodis BioSciences Inc Company Overview
    • 5.11.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Massachusetts Institute of Technology Company Overview
    • 5.12.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Medisse BV (Inactive) Company Overview
    • 5.13.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 N8 Medical LLC Company Overview
    • 5.14.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Nanyang Technological University Company Overview
    • 5.15.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Northwestern University Company Overview
    • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 OptMed Inc Company Overview
    • 5.17.1 OptMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Purdue University Company Overview
    • 5.18.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Tissium SA Company Overview
    • 5.19.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 University of Galway Company Overview
    • 5.20.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 University of Kansas Company Overview
    • 5.21.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6 Tissue Adhesives- Recent Developments

  • 6.1 Aug 30, 2024: Okapi Medical Receives 510(k) Clearance For Cutiva Topical Skin Adhesive
  • 6.2 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM005 Standard (CM005)
  • 6.3 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM00622 LINC Skin Closure System (CM00622 LINC)
  • 6.4 Jul 29, 2024: Connexicon Receives FDA 510(k) Clearance for CM004 Mini (CM004)
  • 6.5 Mar 22, 2024: Meril Endo Surgery Received FDA 510(K) Clearance For Meriglu Topical Skin Adhesive
  • 6.6 Oct 18, 2023: NeoDyne Launches New UK Headquarters to Mark Growth and Expansion in the UK

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials
  • Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials